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1009-84 Implications of Smoking Status on the Response to 
Therapeutic Angiogeneois  In Peripheral Artery Disease: 
Findings From the Therapeutic Angiogenesis With FGF- 
2 for Intermittent Cleudication ('I'RAFRC) Trial 
Joroe F. Saucedo. Mohammed M. Moursi, R. D. Anderson, Farrell O. Mendelsohn, 
James B. Hermiller, Robert Federici, James Zidar, Adam B. Greenbaum, Thomas Moon, 
M. J. Whitahouse, Brian H. Annex, Robert J. Lederman, University of Arkansas for 
Medical Sciences, Little Rock, Arkansas, National Heart Lung and Blood Institute, 
Bethesda, Maryland. 
Background: Fibroblast growth factor-2 (FGF-2) is a potent angiogenic agent in multiple 
preclinical models. A single intra-arterial infusion of 30 mcg/kg rFGF-2 was associated 
with significant improvement in peak walking time (PWT) at 90 days in a phase II, ran- 
domized, placebo-controlled trial in patients with moderate to severe claudication (TRAF- 
FIC). Nicotine has angiogenic activity. A pro specified subgroup analysis was based on 
baseline smoking status. 
Methods: The primary endpoint, change in PWT from baseline to 90 days, was analyzed 
by treatment group (pooling FGF-2 groups) and smoking status at enrollment. 
Results: Current smokers were 38% of the placebo group and 23% of FGF-2 groups. 
Baseline PWTs were comparable among groups. Current smokers had greater increases 
in PW'I" both in placebo and FGF-2 groups compared with non-smokers. 
Conclusion: Non-smokers appeared to derive significantly greater benefit from rFGF-2 
than smokers, despite larger PWT increases in smokers assigned either placebo or FGF- 
2. The large difference between the two placebo groups warrants further evaluation. 
Smoking status needs to be considered in the design of future angiogenesis tudies. 
Variable Currant.Smoker Non-Smoker 
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Placebo All FGF-2 Placebo All FGF-2 
N (evaluable)= 23 25 35 91 
PWT Baseline (min) 5.23+~?..35 5.46+2.98 5.37+~2.69 5.46-+.2.62 
~PWT at 90 d (min) 1.25+2.87 2.17_+1.68 0.18+~2.02 1.54_+2.81 
95% CI around ,~PWT [-0.62, 3.12] [0.16, 4.18] [-0.81, 1.16] [.85, 2.23] 
P-value vs placebo 0.46 0.016 
POSTER SESSION 
1010 Hormonal Influences on Cardiovascular 
Structure and Function 
Sunday, March 17, 2002, 9:00 a.m.-11:00 a.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 9:00 a.m.-10:00 a.m. 
1010-85 Insulin Resistance Is Associated With Left Ventriculer 
Remodeling: The Framingham Heart Study 
Martin K. Rutter, Helen Parise, Martin G. Larson, Emelia J. Benjamin, Daniel Levy, 
James B. Meigs, Richard W. Nesto, Peter W. Wilson, Ramachandran S. Vasan, NHLBI's 
Fremingham Heart Study, Framingham, Massachusetts, Boston Universi~ Boston, 
Massachusetts. 
BACKGROUND: Increased left ventdcular mass (LVM) is a potent cardiovascular isk 
factor but its pathogenesis is inadequately understood. Though insulin resistance has 
been implicated in the development of left ventricutar (LV) hypertrophy and altered geom- 
etry (LV remodeling), prior studies have yielded inconsistent results. 
METHODS: We examined how normal glucose tolerance (NGT), impaired glucose toler- 
ance (IGT) impaired fasting glucose (IFG), and diabetes (World Health Organization 
1998) were related to echocardiogrephic LV measurements in 2637 Fremingham Off- 
spdng Study subjects (1520 women, mean age 53 yrs). We also examined the relations 
of insulin resistance (assessed by fasting insulin and homeostasis model, HOMA-IR) and 
LV measures. 
RESULTS: After adjusting for covariates, LV mass and wall thickness were greater 
across WHO categories of worsening glucose tolerance (p<0.04 for trend across catego- 
ries for both). In subjects with NGT (N=2033), LV mass, wall thickness and relative walt 
thickness increased across quartiles of fasting insulin (Table) and HOMA-IR. Adjustment 
for BMI attenuated these relations, suggesting that LV effects may be partially mediated 
through increasing BMI across quartiles of fasting insulin. 
Quartiles of fasting insutin P (trend)* 
Q1 Q2 Q3 Q4 
LV Mass (g) 156.8 159.9 156.9 162.2 0.032 
LV wall thickness (cm)** 1.86 1.88 1.87 1.90 0.005 
LV internal diameter (cm) 4.73 4.76 4.72 4.75 0.970 
Relative wall thickness 0.396 0.396 0.400 0.403 0.042 
*adjusted for age, sex, height, systolic BP, and heart rate; **sum of interventdcular 
septum and LV posterior wall 
CONCLUSIONS: LV remodeling increased with worsening glucose tolerance. Within the 
NGT group, insulin resistance was associated with greater LV remodeling. Additional 
research is needed to examine if modifying insulin resistance favorably influences LV 
remodeling. 
1010-86 Insulin Improves Alveolar Gas Exchange in Patients 
With Type 2 Diabetes and Heart Failure 
Marco Guazzi, Roberto Brambilla, Stefano DeVita, Maurizio D. Guazzi, Institute of 
Cardiology, University of Mi/ano, Mi/ano, Italy. 
Background, Chronic heart failure (CHF) (hydrostatic stress) and, less commonly, dia- 
betes mellitus (basal laminae thickening), can damage the alveolar-capillary membrane. 
We probed whether coexistence of diabetes worsens pulmonary gas transfer in CHF, 
and whether insulin improves this effect. 
Methods and Results. 15 controls and 25 CHF patients were investigated. 11 patients 
(group 1) were normoglycemic and 14 (group 2) had type 2 diabetes. Cardiac function, 
pulmonary diffusion (DLco) and its subdivisions, D M (membrane conductance) and V c 
(pulmonary capillary blood), were assessed at rest. In patients, measurements were 
repeated following infusion of 50 ml saline + regular insulin (10 IU), or saline alone, in two 
consecutive days (random crossover design). 
At rest, compared to controls, reduction in ejection fraction (EF) and elevation in wedge 
pulmonary pressure (wpp) were similar in groups 1 and 2; DLco (percent normal and 
absolute values), D a and DM/alveolar volume were more reduced (p < 0.01 ), and DLco/ 
D u was more raised (p < 0.01) in group 2. Saline in groups 1 and 2, and insulin in group 
1 were ineffective. Insulin in group 2 significantly (p<0.01) augmented DLco (+17%) and 
D M (+26.5%), reduced DLco/D M (from 74+8.8 % to 63+9.9%) and did not affect EF and 
wpp. There was no correlation between changes in D u and those in blood sugar. 
Conclusions. Diabetes potentiates gas diffusion impairment in CHI£ Insulin counteracts 
this effect by improving the alveolar-capillary conductance. We suggest that insulin 
releases substances (nitric oxide, vasedilating prostaglandins) active on the "leacky' pul- 
monary capillaries, or enhances sodium absorption from alveolar lumen (glucose-sodium 
co-transport mechanism), thus shortening the distance between blood and alveoli, and 
facilitating as transfer. 
1 010-87 Long-Term Cardiovascular Effects of Troglitazone on 
NondiabeUc Individuals With Insulin Resistance: 
Double Blind Prospective Randomized Study 
Dimitrios Stakos. Elizabeth Sparks, Dara Schuster, Kwame Osei, Charles Wooley, 
Harisios Boudoulas, Ohio State University Medical Center, Columbus, Ohio. 
Background: The beneficial effect of oral hypoglycemic agents in diabetic patients is 
mainly attributed to glycemic control. While it has been suggested that treatment with oral 
antidiabetic Troglitazone (TGL) or similar agents may prevent cardiovascular complica- 
tions in non-diabetic individuals with insulin resistance, the long-term cardiovascular 
effects of these agents remains unknown. 
Methods: In 137 African-American offspring of type 2 diabetic parents with normal glu- 
cose tolerance test (OGTT) and insulin resistance, TGL 200 mg/d (n = 40) or identical 
placebo tablets (n = 97) were given for 24 months. Insulin sensitivity; total, high density 
lipoprotein, low density lipoprotsin cholesterol, and triglycarides; brachial artery blood 
pressure (sphygmomanometry); left ventricular diameters and mass (echo); and aortic 
pulse wave velocity (PWV, carotid to femoral artery, Doppler) were measured at baseline, 
at 12 and at 24 months after randomization. 
Results: No significant changes in OGTT, insulin sensitivity or lipids profile were 
observed in either group during the follow-up period. PWV in the placebo group did not 
change significantly (baseline 9.6 ± 2.4 m/sac, 12 months 10.7 ± 2.4 m/sec, 24 months 
10.1 ± 2.6 m/sac). In contrast, PWV increased significantly in the TGL group (baseline 
8.9 ± 1.6 m/sac, 12 months 9.9 ± 2.1 m/sec, 24 months 10.7 ± 2.3 m/sac, ANOVA p = 
0.0002). Compared to baseline, PWV was increased both at 12 (p<0.01) and at 24 
months (p<0.001). Systolic blood pressure decreased slightly in the control group, and 
remained unchanged in the TGL group. The increase in PWV is consistent with a 
decrease in the elastic properties of the aorta. LV diameters, % shortening of the LV 
internal diameter and LV mass, did not change significantly in either group dudng the fol- 
low-up period. 
Conclusion: Long-term administration of TGL to non-diabetic African-Americans with 
insulin resistance may decrease the elastic properties of the aorta. Thus, long-term ther- 
apy with TGL or similar agents for the prevention of cardiovascular complications to non- 
diabetic individuals with insulin resistance needs to be critically evaluated. 
1010-88 Estrogen Improves Arterial Stiffness in 
Postmenopeusal  Diabetic Women 
Amit Nussbacher. Claudia Sztejnsznajd, Elizabeth Silva, Otavio C. Gebara, Jo~o B. 
Serro-Azul, Humberto Pierd, Silvia Lage, Giuseppe Rosano, Mauricio Wajngarten, Jos~ 
Antonio E Ramires, Heart Institute (InCor), University of Sag Paulo Medic, el School, S~o 
Pau/o, Brazil, Division of Endocdno/ogy, University of S~o Paulo Medical School, S&o 
Pau/o, Brazil 
Diabetes is associated with increased cardiovascular morbidity and mortality. The effects 
of estrogen replacement herapy on arterial compliance in postmenopausal diabetic 
women has not been fully investigated. The goal of this study was to evaluate the acute 
and chronic effects of estrogen on artedal stiffness in 14 postmenopausal women with 
type 2 diabetes aged 56±4 years and with a body mass index of 28.2±2.5 kg.m-2. 
Patients underwent noninvasive assessment of two indices of arterial stiffness: cartotid 
artery augmentation index (AGI) and carotid-femoral pulse wave velocity (PWV). Mea- 
surements were performed at baseline (BL), 20 minutes after 1.25 mg of intravenous 
conjugated equine estrogen (CEE) (ACUTE), and after 4 months of 0.625 m~/day oral 
CEE (CHRONIC). As shown in table, mean arterial pressure (MAP), heart rate (HR) and 
AGI were not changed whereas PWV was reduced both acute and chronically (*=p<0.05 
vs. BL). 
Therefore, in postmenopausal diabetic women with stiff vasculature (elevated baseline 
CL 
208A 
AGI and PWV), acute and chronic estrogen replacement improves vascular compliance 
independently of changes in blood pressure. Hemodynamic benefits of hormone replace- 
ment therapy/may be padicutarl~/evident i  hese patients with stiff vasculature. 
MAP HR AGI PWV 
(mmHg) (bpm) (%) (cm/s) 
BL 104±14 66±11 38.7±7.8 936±269 
ACUTE 103±15 64±15 40.3±7.9 821 ±213* 
CHRONIC 101 ±14 66±12 36.8±6.5 820±218* 
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* = p<0.01 
1010-89 Sildenafil (ViagraO) Decreases Wave Reflection in 
Hypertensive Patients 
Charalambos Vlachoooulos, KOZO Hirata, Christodoulos Stefanadis, PavIos Toutouzas, 
Michael O'Rourke, Henry Dunant Hospital, Athens, Greece, SL Vincent's Hospital, 
University of New South Wales, Sydney, Australia. 
Background: Sildenafil (Viagra®, S) is an effective drug for erectile dysfunction acting on 
the metabolism of nitric oxide. However, its effects on the cardiovascular system have 
not been thoroughly studied. Wave reflection (WR) along the arterial tree is an important 
index of adedal stiffening and cardiac afterloed and is inversely associated with exercise 
capacity. 
Methods: We studied 17 hypertensives(age 72~7 years) in a randomized, double-blind, 
cross-over fashion (50 mg of S and placebo). WR was studied using a validated system 
(Sphygmcoo~)) that employs (i) high-fidelity arterial tonometry (Miller tonometer) for the 
non-invasive registration of radial pulse waveform and (ii) appropriate computer software 
for pulse wave analysis. Aortic pressure waveform was synthesized from the radial 
waveform using a generalized transfer function. Augmentation index (=dP/PP %, fig.: 
waveform) was measured as an index of wave reflection. Lower values of augmentation 
index indicate reduced arterial stiffening and reduced cardiac load and vice-versa. 
Results: S caused a decrease in aortic systolic and diastolic pressure (by 16.2 and 10.1 
mmHg respectively; P<.001 for both). S led to a significant decrease in augmentation 
index indicating decreased effect of WR from the periphery (fig.: trends). 
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Conclusions: S leads to a decrease of WR in hypertensives. This has important implica- 
tions for artedal stiffening and the pulsatile load of the heart and may contribute to 
improved exercise capacity at intercourse. 
1010-90 The Effects of Menstrual Cycle on Cardiac Autonomic 
Innervation as Assessed by Heart Rate Variability 
Avlin Yiididr. Giray Kabakci, Ebru Akgu~, Lale Tokgozoglu, All Oto, Baskent Universi~ 
Ankara, Turkey, Hacettepe Universi~ Ankara, Turkey. 
Aim: A wide spectrum of biological functions is regulated by the cyclic changes in estro- 
gen and progesterone levels during regular menstrual cycle, however little information is 
available concerning the interrelationship of these hormones and cardiovascular auto- 
nomic function. The aim of this study was to investigate the characteristics of cardiac 
autonomic innervation during the two phases of menstrual cycle by heart rate variability 
(HRV). 
Methods: Forty-three regularly cycling non-obese (BMI: 24±1kg/m2) women with a mean 
age of 29±6 years (range 20-38) were enrolled, The power spectral analysis of HRV was 
used to calculate low frequency component (0.03-0.15Hz) in absolute (LF) and normal- 
ized units (LF nu), high frequency component (0.15-0.40 Hz) in absolute (HF) and nor- 
malized units (HF nu) and LF/HF ratio at the peaks of estrogen and progesterone levels 
during the menstrual cycle (follicular phase 11±1 days; luteal phase 21±2 days from the 
first day of bleeding). 
Results: A significant increase was noted in the LF nu in the luteal phase compared to 
follicular phase (p=0.014), whereas, a tendency for increased HF nu was observed in the 
follicular phase (p=0.053). Furthermore, LF/HF ratio was significantly higher in the luteal 
phase compared to follicular phase (p=0.O02), indicating an increased sympathetic activ- 
ity. 
Follicular Luteal P 
LF (m/sn2) 461.5±501.8 559,1 ±539.5 0.199 
LF nu 53.7±12.7 58.2±14.2 0.014 
HF (m/sn2) 384.9±480.8 395.6±351.8 0.842 
HF nu 39.7±12.4 36.6±13.9 0.063 
LF/HF 1.6±0.9 2.1 ±1.5 0.002 
Conclusion: We concluded that regulation of autonomic tone is modified during men- 
strual cycle. The alteration in the balance of ovarian hormones might be responsible for 
these changes. 
1011-69 Effects of Intensive Cardiovascular Risk Factor 
Management on Endothelial Function and 
Angiogenesis in 'high risk' Hypertensive Patients 
Dirk C. Felmeden. Charles G. Spencer, Funmi M. Belgore, Andrew D. Blann, Gareth D. 
Beevers, Gregory Y. Lip, Haemostasis, Thrombosis, and Vascular Biology Unit, 
University Department of Medicine, City Hospital, Birmingham, United Kingdom. 
Backeround: Hypertensive patients are at particular isk of vascular complications, which 
may be related to endothelial dysfunction or abnormal angiogenesis. We investigated 
these pathophysiological processes in 'high risk' hypertensives and evaluated the 
response to intensive cardiovascular isk management (blood pressure reducing and if 
required lipid-towering therapy) after 6 months. 
Patients and Methods:. We studied 89 'high-risk' hypertensive patients (78 males; mean 
age 64 years, SD 8.4). High-resolution ultrasound was used to assess endothelium- 
dependent brechial artery flow mediated dilatation (FMD) following vessel occlusion. 
Plasma levels of yon Wiflebrand factor (vWf), vascular endothelial growth factor (VEGF) 
and its soluble receptor (sFIt-1) were analysed by ELISA. 
Results: There was a significant correlation between FMD and levels of vWf (Spearman, 
R~ 0.517), VEGF (R=-0.314) and sFIt-1 (R=0.328). FMD was significantly correlated 
with CHD risk according to the Framingham equation (R=-0.624; all p< 0.001). 
Conclusion: Hypertensive patients demonstrate endothelial dysfunction and dysregu- 
lated angioganesis, which improved following intensive cardiovascular isk factor man- 
agement. Plasma VEGF and vWf levels might be useful tools to identify patients at dsk of 
future cardiovascular events and may assist in the understanding of the early develop- 
ments in the pathogenesis of vascular risk in hypertension. 
Results 
Baseline After 6 monhts treatment p-value 
total cholesterol [mmoi/I] 6.1 (0.9) 5.4 (1.2) <0.001 
SBP [mmHg] 167 (17) 146 (16) 0.004 
DBP [mmHg] 91 (9) 83 (10) <0.001 
FMD[%] 4.89 (1.61) 7.33 (2.00) 0.001 
vWf [IU/dl] 141 (29) 125 (25) <0.001 
VEGF [pg/ml] 300 (183-1275) 210 (123-686) <0.001 
sFIt-1 [ng/ml] 5.2 (1.7-13.5) 7.2 (2.3-17.6) <0.001 
1011-70 Socioeconomic Status and Cardiovascular Risk Factors 
in a Brazilian Young Population Followed Up for a 10- 
Year Period: The Rio de Janeiro Study 
Andrea A. Brandao. Roberto Pozzan, Maria Eliane C. Magalh&es, Ayrton P. Brand&o, 
State University of Rio de Janeiro, Rio de Janeiro, Brazil. 
Background: Low socioeconomic status (SES) has been related to hypertension and 
other cardiovascular isk factors and predicts poor outcomes in adult populations. We 
investigated the aggregation of high blood pressure (BP), overweight, metabolic abnor- 
malities and left ventdcular mass (LVM) in young subjects, according to their school's 
SES obtained 10 years earlier. 
Methods: 385 young subjects (201M) were evaluated at their schools in 1987-88 
(12.74±1.65 y). BP was measured 3 times, and the third measure was used for analysis. 
Body mass index (BMI) was obtained. In 1997-98 (21,91±2,12 y), they were examined at 
the hospital. BP and BMI were obtained and cholesterol (C), tryglicerides, LDL-C, HDL- 
C, glucose and insulin were measured after at2h fasting. LVM was obtained by echocar- 
diography, using the Penn's formula. The sample was stratified according to school's 
SES (low, medium, high), reported by Secretary of Education for Rio de Janeiro, regard- 
ing parents' occupation and monthly income. GI: low SES (n=68, 29M); G2: medium 
SES (n=141, 83M); G3: high SES (n=176, 89M). Comparisons were adjusted for age and 
sex. Risk factors considered were: BP >= 140 and/or 90 mmHg, glucose >= 110 mg/dl, 
BMI >= 25 kg/m2, insulin >= 30 mlU/ml, smoking, familiar history of myocardial infarction 
at early age and any alteration of lipids. 
Results: 1)G1 had higher diastolic BP at school than G2 and G3 (p<.03); 2)After 10 
years, G1 had higher systolic (p<.02) and diastolic BP (p<.Ol), positive BMI variation 
between the two evaluations (p<.01), LVM (p<.04) and LVM index (p<.01), and lower 
HDL-C (p<.O5) than G3; 3) Ten years later, compared to G3, G1 had higher prevalence of 
hypertension (27.9X17%), overweight (35.8X25%) and hyperinsulinemia (6.7X3%) 
(p<.05); 4) In G1, 36.5% had 3 risk factors or more, compared to 27.6% in G2 and 22.4% 
in G3 (p<.Ol); 5) In logistic regression, male sex, low SES, high BP and overweight at 
school were significantly related to hypertension in a 10 year-period (RR=3.97, 1.47, 
2.58, 2.93, respectively; p<.05). 
Conclusion: School's low SES was associated to overweight, higher BP and LVM, lower 
HDL-C and high risk factor aggregation in Brazilian young subjects, 10 years later. 
